Baird Multiple Sclerosis Center Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2001
NCT00304291
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now